Alignment Healthcare (ALHC) Q4 FY25 earnings call

Alignment Healthcare delivered a strong Q4 FY25, exceeding profitability guidance and demonstrating significant margin expansion for the full year, driven by membership growth and operational efficiency. The company is confident in its clinically-led model to navigate a challenging reimbursement environment, including the final phase-in of V28 and utilization pressures. Strategic investments in ex-California markets and AI workflows are planned to sustain growth and scalability, with a focus on disciplined expansion and long-term embedded earnings potential.